IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $33,362,000 | -49.4% | 1,747,622 | -34.7% | 2.57% | -51.3% |
| Q3 2021 | $65,948,000 | +18.5% | 2,674,299 | +25.1% | 5.28% | +2.9% |
| Q2 2021 | $55,631,000 | +33.8% | 2,137,999 | +62.8% | 5.13% | +53.9% |
| Q1 2021 | $41,570,000 | -31.8% | 1,312,999 | 0.0% | 3.33% | -28.9% |
| Q4 2020 | $60,923,000 | +40.9% | 1,312,999 | 0.0% | 4.69% | +20.9% |
| Q3 2020 | $43,224,000 | +19.9% | 1,312,999 | 0.0% | 3.88% | +22.6% |
| Q2 2020 | $36,042,000 | -31.2% | 1,312,999 | -25.0% | 3.16% | -46.7% |
| Q1 2020 | $52,406,000 | +8.1% | 1,750,665 | 0.0% | 5.94% | -26.9% |
| Q4 2019 | $48,458,000 | +52.1% | 1,750,665 | 0.0% | 8.13% | -18.4% |
| Q3 2019 | $31,862,000 | -40.6% | 1,750,665 | -20.0% | 9.96% | -27.5% |
| Q2 2019 | $53,658,000 | +157.8% | 2,188,331 | 0.0% | 13.75% | +174.4% |
| Q1 2019 | $20,811,000 | +7.5% | 2,188,331 | 0.0% | 5.01% | +0.3% |
| Q4 2018 | $19,367,000 | -21.3% | 2,188,331 | 0.0% | 5.00% | +10.8% |
| Q3 2018 | $24,619,000 | -12.1% | 2,188,331 | 0.0% | 4.51% | -22.3% |
| Q2 2018 | $28,011,000 | -24.3% | 2,188,331 | 0.0% | 5.80% | -5.5% |
| Q1 2018 | $36,983,000 | +111.2% | 2,188,331 | 0.0% | 6.14% | +116.2% |
| Q4 2017 | $17,507,000 | +3.2% | 2,188,331 | 0.0% | 2.84% | -53.1% |
| Q3 2017 | $16,960,000 | +11.5% | 2,188,331 | 0.0% | 6.05% | -22.4% |
| Q2 2017 | $15,209,000 | – | 2,188,331 | – | 7.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |